Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2938)
All Articles published online
|
Sep 28, 2008 (publication date) through Feb 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Ricart E, García-Bosch O, Ordás I, Panés J. Are we giving biologics too late? The case for early |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i36/5523.htm |
| Number | Citing Articles |
| 1 |
Alain M Schoepfer, Mohamed-Ali Dehlavi, Nicolas Fournier, Ekaterina Safroneeva, Alex Straumann, Valérie Pittet, Laurent Peyrin-Biroulet, Pierre Michetti, Gerhard Rogler, Stephan R Vavricka. Diagnostic Delay in Crohn's Disease Is Associated With a Complicated Disease Course and Increased Operation Rate. American Journal of Gastroenterology 2013; 108(11): 1744 doi: 10.1038/ajg.2013.248
|
| 2 |
Salvador Pous-Serrano, Matteo Frasson, Jose Pàmies-Guilabert, Polina Rudenko, Icíar Puchades-Roman, Belén Beltrán, Pilar Nos Mateu, Eduardo García-Granero. Use of Magnetic Resonance Index of Activity (MaRIA) in the Preoperative Assessment of Small Bowel Crohn’s Disease. Cirugía Española (English Edition) 2019; 97(10): 582 doi: 10.1016/j.cireng.2019.11.006
|
| 3 |
Jacob Tveiten Bjerrum, Yulan Wang, Fuhua Hao, Mehmet Coskun, Christian Ludwig, Ulrich Günther, Ole Haagen Nielsen. Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals. Metabolomics 2015; 11(1): 122 doi: 10.1007/s11306-014-0677-3
|
| 4 |
Elizabeth A. Scoville, Margaret M. Allaman, Caroline T. Brown, Amy K. Motley, Sara N. Horst, Christopher S. Williams, Tatsuki Koyama, Zhiguo Zhao, Dawn W. Adams, Dawn B. Beaulieu, David A. Schwartz, Keith T. Wilson, Lori A. Coburn. Alterations in lipid, amino acid, and energy metabolism distinguish Crohn’s disease from ulcerative colitis and control subjects by serum metabolomic profiling. Metabolomics 2018; 14(1) doi: 10.1007/s11306-017-1311-y
|
| 5 |
Michele Carvello, Silvio Danese, Antonino Spinelli. Surgery versus Medical Therapy in Luminal Ileocecal Crohn's Disease. Clinics in Colon and Rectal Surgery 2022; 35(01): 072 doi: 10.1055/s-0041-1740031
|
| 6 |
José Ignacio Fortea-Ormaechea, Yago González-Lama, Begoña Casis, María Chaparro, Pilar López Serrano, Manuel Van Domselaar, Fernando Bermejo, Ramón Pajares, Ángel Ponferrada, María Isabel Vera, Pilar Martínez Montiel, Javier P. Gisbert, José Luis Pérez-Calle, Antonio López San Román, Luis Abreu, Luis Alberto Menchén, Ignacio Marín-Jiménez. Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience. Gastroenterología y Hepatología 2011; 34(7): 443 doi: 10.1016/j.gastrohep.2011.04.001
|
| 7 |
Matteo Frasson, Luis Sendra, Antonio Miguel, Maria José Herrero, Eva Montalvá, Rafael López-Andújar, Juan Martínez-Pastor, Luis Martí-Bonmatí, Eduardo García Granero, Salvador Aliño. Hydrodynamic IL10 Gene Transfer in Human Colon. Inflammatory Bowel Diseases 2017; 23(8): 1360 doi: 10.1097/MIB.0000000000001197
|
| 8 |
Salvador Pous-Serrano, Matteo Frasson, José Pàmies-Guilabert, Polina Rudenko, Icíar Puchades-Román, Belén Beltrán, Pilar Nos Mateu, Eduardo García-Granero. La resonancia magnética y el índice MaRIA en la valoración preoperatoria de la enfermedad de Crohn ileal. Cirugía Española 2019; 97(10): 582 doi: 10.1016/j.ciresp.2019.06.018
|
| 9 |
Jeffrey W. Molloy, Joel Z. Stengel, Hays L. Arnold. Infliximab: A Review of its Use in the Treatment of Crohn's Disease. Clinical Medicine. Therapeutics 2009; 1 doi: 10.4137/CMT.S2250
|
| 10 |
Naoto Saigusa, Tadashi Yokoyama, Masaru Shinozaki, Ryoji Miyahara, Tsuyoshi Konishi, Toshio Nakamura, Yasuhisa Yokoyama. Anorectal fistula is an early manifestation of Crohn’s disease that occurs before bowel lesions advance: a study of 11 cases. Clinical Journal of Gastroenterology 2013; 6(4): 309 doi: 10.1007/s12328-013-0404-z
|
| 11 |
Ho Suk Kang, Ja Seol Koo, Kang Moon Lee, Dae Bum Kim, Ji Min Lee, Yoon Jae Kim, Hyuk Yoon, Hyun Joo Jang. Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use. World Journal of Gastroenterology 2019; 25(8): 989-1001 doi: 10.3748/wjg.v25.i8.989
|
| 12 |
Roy Frei, Nicolas Fournier, Jonas Zeitz, Michael Scharl, Bernhard Morell, Thomas Greuter, Philipp Schreiner, Benjamin Misselwitz, Ekaterina Safroneeva, Alain M Schoepfer, Stephan R Vavricka, Gerhard Rogler, Luc Biedermann. Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn’s Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study. Journal of Crohn's and Colitis 2019; 13(10): 1292 doi: 10.1093/ecco-jcc/jjz057
|
| 13 |
Arkady Broder, Joel R. Rosh. Infliximab: A Review of its use in the Treatment of Pediatric Crohn's Disease. Clinical Medicine Insights: Therapeutics 2010; 2 doi: 10.4137/CMT.S2840
|
| 14 |
Giovanni Latella, Renzo Caprilli, Simon Travis. In favour of early surgery in Crohn's disease: A hypothesis to be tested. Journal of Crohn's and Colitis 2011; 5(1): 1 doi: 10.1016/j.crohns.2010.11.003
|
| 15 |
Stephan R. Vavricka, Sabrina M. Spigaglia, Gerhard Rogler, Valérie Pittet, Pierre Michetti, Christian Felley, Christian Mottet, Christian P. Braegger, Daniela Rogler, Alex Straumann, Peter Bauerfeind, Michael Fried, Alain M. Schoepfer. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflammatory Bowel Diseases 2012; 18(3): 496 doi: 10.1002/ibd.21719
|
| 16 |
Marco Gasparetto, Graziella Guariso. Crohn's disease and growth deficiency in children and adolescents. World Journal of Gastroenterology 2014; 20(37): 13219-13233 doi: 10.3748/wjg.v20.i37.13219
|
| 17 |
Manuel Barreiro-de Acosta, Aurelio Lorenzo, Jose Mera, J. Enrique Dominguez-Muñoz. Mucosal healing and steroid-sparing associated with infliximab for steroid-dependent ulcerative colitis. Journal of Crohn's and Colitis 2009; 3(4): 271 doi: 10.1016/j.crohns.2009.06.003
|
| 18 |
Laila El Shabrawi-Caelen, Michelangelo La Placa, Colombina Vincenzi, Thomas Haidn, Robert Muellegger, Antonella Tosti. Adalimumab-induced psoriasis of the scalp with diffuse alopecia: A severe potentially irreversible cutaneous side effect of TNF-alpha blockers. Inflammatory Bowel Diseases 2010; 16(2): 182 doi: 10.1002/ibd.20954
|